Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-14 4:05 pm Purchase | 2021-10-04 | 13G | Viridian Therapeutics, Inc. VRDN | Venrock Healthcare Capital Partners III, L.P. | 1,943,055 9.990% | 1,943,055 (New Position) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | Venrock Healthcare Capital Partners III, L.P. | 4,040,000 4.000% | 1,250,000 (+44.80%) | Filing History |
| 2021-02-16 4:08 pm Sale | 2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Venrock Healthcare Capital Partners III, L.P. | 917,860 3.700% | -825,528 (-47.35%) | Filing History |
| 2020-11-04 4:54 pm Purchase | 2020-10-08 | 13G | Cardiff Oncology, Inc. CRDF | Venrock Healthcare Capital Partners III, L.P. | 1,714,286 5.700% | 1,714,286 (New Position) | Filing History |
| 2020-11-04 4:52 pm Purchase | 2020-10-16 | 13G | Galera Therapeutics, Inc. GRTX | Venrock Healthcare Capital Partners III, L.P. | 1,743,388 7.000% | 1,743,388 (New Position) | Filing History |